Infographic showing how prescriptions for new Type 2 Diabetes classes increased over time for older patients with expanded Medi-Cal coverage in California. The left graph displays rising predicted probabilities of SGLT2 inhibitor or GLP-1RA prescriptions, with a notable increase in May 2022. The right panel explains that undocumented immigrants became newly eligible for Medi-Cal in June 2023, leading to similar prescription rates for these newer diabetes treatments compared to other groups. A small map of the United States highlighting California is in the top right corner.
CA’s 2022 MediCal expansion for undocumented 50+ led to more prescriptions for newer T2D meds. Prescriptions for undocumented patients matched documented levels by June 2023. #MediCalExpansion
Read here ➡️ doi.org/10.2337/dc25-0787